StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

How the market prices Addex Therapeutics

Each ratio against its own distribution since 2020, from month-end prices and the figures reported at the time

Addex Therapeutics trades at 2.0× its earnings, against a median of 0.2× since 2020 — dearer than 93% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2020, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2020

Median 0.2×, today 2.0×

Margins

Operating margin-9390.8%
EBITDA margin-9390.8%
Pretax margin-22829.9%
Free cash flow margin-7243.8%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on capital employed-133.0%vs -133.0%

How hard the assets work

Revenue per dollar of assets0.01
Revenue per employeeCHF 9.99K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by CHF 767.33K.

Cash and short-term investmentsCHF 767.33K
EBITDA, trailing twelve months-CHF 2.81M
Free cash flow, trailing twelve months-CHF 2.17M

Leverage and liquidity

Current ratio0.76vs 2.65
Quick ratio0.58vs 2.21

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

-148.95
DistressGrey zoneSafe

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Free cash flow yield-3601.4%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

52
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ADXNS&P 500
PeriodADXNS&P 500DifferenceADXN per yearS&P 500 per year
1 month+26.8%-4.0%+30.8 pts
3 months-38.6%-5.0%−33.6 pts
Year to date-54.7%+8.2%−62.9 pts
1 year-58.3%+11.2%−69.6 pts
3 years-41.7%+68.5%−110.1 pts-16.4%+19.0%
5 years-97.7%+67.3%−164.9 pts-52.9%+10.8%

How much it moves

Volatility, 1 year118.0%
Volume against its 90-day average0.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ADXN shares were sold short on Oct 30, 2026, up 6.4% from the previous report. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 55.6% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Days of volume to buy it back1.59

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,970+6.4%3,7461.6
Oct 15, 20265,613+205.1%8,3011.0
Sep 30, 20261,840+589.1%21,0281.0
Sep 15, 2026267-93.5%53,6041.0
Aug 31, 20264,133-41.6%656,2081.0
Aug 14, 20267,083+70.6%8488.3
Jul 31, 20264,153+351.4%1,0933.8
Jul 15, 2026920-39.0%1,7871.0
Jun 30, 20261,509+12.3%5,5941.0
Jun 15, 20261,344-73.0%4,3131.0
May 29, 20264,982-0.5%1,7792.8
May 15, 20265,006+0.3%2,9591.7

Every measure, in full

58 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
CHF 60.29K
–
Enterprise Value
-CHF 707.04K
–
PS Ratio
2.01
–

Enterprise valuationIndustry

EV / Sales
-23.59
–

Share statisticsIndustry

Shares Change (YoY)
9.44%
10.4%
Float
125M
47M
Shares Held by Insiders
15.5%
7.99%
Shares Held by Institutions
0.00%
–

Short sellingIndustry

Short Interest
5,970
–
Short Interest Change
6.36%
–
Days to Cover
1.59
–

Stock price statisticsIndustry

Price Change (1 Week)
21.1%
–
Price Change (1 Month)
21.1%
–
Price Change (3 Months)
-38.6%
–
Price Change (6 Months)
-50.0%
–
Price Change (YTD)
-54.7%
–
Price Change (1 Year)
-58.7%
–
Price Change (3 Years)
-41.7%
–
Price Change (5 Years)
-97.7%
–
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
426,713
–
Relative Volume
0.13
–
Relative Strength Index (14)
52.3
–
Volatility (1 Year)
118.0%
–

MarginsIndustry

Operating Margin
-9390.8%
–
Pretax Margin
-22829.9%
–
EBITDA Margin
-9390.8%
–
FCF Margin
-7243.8%
–

Returns on capitalIndustry

Return on Capital Employed (ROCE)
-133.0%
-133.0%

Financial positionIndustry

Current Ratio
0.76
2.65
Quick Ratio
0.58
2.21
Interest Coverage
-181.04
-116.78

GrowthIndustry

Revenue Growth (YoY)
-92.6%
–
EPS Growth (YoY)
-185.7%
–
Revenue Growth (3Y CAGR)
-72.4%
–
Revenue Growth (5Y CAGR)
-61.6%
–

EfficiencyIndustry

Asset Turnover
0.01
–
Revenue Per Employee
CHF 9.99K
–
Employee Count
3
49

Income statement (TTM)Industry

Revenue
CHF 29.97K
–
Operating Income
-CHF 2.81M
-CHF 69.32M
Pretax Income
-CHF 6.84M
-CHF 70.45M
EBITDA
-CHF 2.81M
-CHF 69.32M
EPS (Diluted)
-0.06 CHF
-1.65 CHF

Balance sheetIndustry

Cash & Short-Term Investments
CHF 767.33K
CHF 27.76M
Net Cash (Debt)
CHF 767.33K
CHF 27.76M
Net Cash Per Share
0.01 CHF
1.03 CHF
Working Capital
-CHF 326.37K
CHF 11.40M

Cash flow (TTM)Industry

Operating Cash Flow
-CHF 2.17M
-CHF 51.26M
Capital Expenditures
CHF 0
-CHF 446.00K
Free Cash Flow
-CHF 2.17M
-CHF 51.97M
FCF Per Share
-0.01 CHF
-1.11 CHF

Dividends and yieldsIndustry

FCF Yield
-3601.4%
–

Taxes and interestIndustry

Interest Expense
CHF 15.55K
CHF 833.00K
Income Tax
CHF 0
CHF 0

Scores and fair valueIndustry

Altman Z-Score
-148.95
–

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?